Niacin activates the G protein estrogen receptor (GPER)-mediated signalling

Cellular Signalling

Volumn 26, Issue 7, 2014, Pages 1466-1475

  Santolla, Maria Francesca ^a   De Francesco, Ernestina Marianna ^a   Lappano, Rosamaria ^a   Rosano, Camillo ^b   Abonante, Sergio ^c   Maggiolini, Marcello ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Regional Hospital   (Italy)

Author keywords

Breast cancer cells; Cancer associated fibroblasts; GPER; Nicotinamide; Nicotinic acid

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; G PROTEIN ESTROGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE; NICOTINIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; HCAR2 PROTEIN, HUMAN; NICOTINIC RECEPTOR; SMALL INTERFERING RNA; VITAMIN B COMPLEX;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL TUBE; ENDOTHELIUM; FIBROBLAST; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; AGONISTS; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CHEMICAL STRUCTURE; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; METABOLISM; MOLECULAR DOCKING; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; NIACIN; NIACINAMIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B COMPLEX;

EID: 84897510110     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.03.011     Document Type: Article

References (55)

1. Prossnitz E.R., Barton M. Nat. Rev. Endocrinol. 2011, 7:715-726.
2. Prossnitz E.R., Maggiolini M. Mol. Cell. Endocrinol. 2009, 308:32-38.
3. Maggiolini M., Picard D. J. Endocrinol. 2010, 204:105-114.
4. Albanito L., Lappano R., Madeo A., Chimento A., Prossnitz E.R., Cappello A.R., Dolce V., Abonante S., Pezzi V., Maggiolini M. Environ. Health Perspect. 2008, 116:1648-1655.
5. Pupo M., Pisano A., Lappano R., Santolla M.F., De Francesco E.M., Abonante S., Rosano C., Maggiolini M. Environ. Health Perspect. 2012, 120:1177-1182.
6. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., Montanaro D., Musti A.M., Picard D., Andò S. J. Biol. Chem. 2004, 279:27008-27016.
7. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. EMBO J. 2009, 28:523-532.
8. Madeo A., Maggiolini M. Cancer Res. 2010, 70:6036-6046.
9. Santolla M.F., Lappano R., De Marco P., Pupo M., Vivacqua A., Sisci D., Abonante S., Iacopetta D., Cappello A.R., Dolce V., Maggiolini M. J. Biol. Chem. 2012, 287:43234-43245.
10. Pupo M., Vivacqua A., Perrotta I., Pisano A., Aquila S., Abonante S., Gasperi-Campani A., Pezzi V., Maggiolini M. Mol. Cell. Endocrinol. 2013, 376:23-32.
11. Smith H.O., Arias-Pulido H., Kuom D.Y., Howard T., Qualls C.R., Lee S.J., Verschraegen C.F., Hathaway H.J., Joste N.E., Prossnitz E.R. Gynecol. Oncol. 2009, 114:465-471.
12. Filardo E.J., Graeber C.T., Quinn J.A., Resnick M.B., Giri D., De Lellis R.A., Steinhoff M.M., Sabo E. Clin. Cancer Res. 2006, 12:6359-6366.
13. Vivacqua A., Romeo E., De Marco P., De Francesco E.M., Abonante S., Maggiolini M. Breast Cancer Res. Treat. 2012, 133:1025-1035.
14. De Marco P., Bartella V., Vivacqua A., Lappano R., Santolla M.F., Morcavallo A., Pezzi V., Belfiore A., Maggiolini M. Oncogene 2013, 32:678-688.
15. De Francesco E.M., Lappano R., Santolla M.F., Marsico S., Caruso A., Maggiolini M. Breast Cancer Res. 2013, 15:R64.
16. Recchia A.G., De Francesco E.M., Vivacqua A., Sisci D., Panno M.L., Andò S., Maggiolini M. J. Biol. Chem. 2011, 286:10773-10782.
17. Vivacqua A., Lappano R., De Marco P., Sisci D., Aquila S., De Amicis F., Fuqua S.A., Andò S., Maggiolini M. Mol. Endocrinol. 2009, 23:1815-1826.
18. MacKay D., Hathcock J., Guarner E. Nutr. Rev. 2012, 70:357-366.
19. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline, Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline 1998, 123-144. National Academies Press (US), Washington, DC.
20. Le Floc'h N., Otten W., Merlot E. Amino Acids 2011, 41:1195-1205.
21. Carleson L.A. J. Intern. Med. 2005, 258:94-114.
22. Brown B.G., Zhao X.Q. Am. J. Cardiol. 2008, 101:58B-62B.
23. Wise A., Foord S.M., Fraser N.J., Barnes A.A., Elshourbagy N., Eilert M., Ignar D.M., Murdock P.R., Steplewski K., Green A., Brown A.J., Dowell S.J., Szekeres P.G., Hassall D.G., Marshall F.H., Wilson S., Pike N.B. J. Biol. Chem. 2003, 278:9869-9874.
24. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Annu. Rev. Nutr. 2007, 27:79-101.
25. Karpe F., Frayn K.N. Lancet 2004, 363:1892-1894.
26. Tunaru S., Lättig J., Kero J., Krause G., Offermanns S. Mol. Pharmacol. 2005, 68:1271-1280.
27. Li F., Chong Z.Z., Maiese K. Curr. Med. Chem. 2006, 13:883-895.
28. Fukuwatari T., Ebata M., Sasaki R. J. Home Econ. 2005, 56:265-272.
29. Lappano R., Santolla M.F., Pupo M., Sinicropi M.S., Caruso A., Rosano C., Maggiolini M. Breast Cancer Res. 2012, 14:R12.
30. Lappano R., Rosano C., De Marco P., De Francesco E.M., Pezzi V., Maggiolini M. Mol. Cell. Endocrinol. 2010, 320:162-170.
31. Lappano R., Rosano C., Santolla M.F., Pupo M., De Francesco E.M., De Marco P., Ponassi M., Spallarossa A., Ranise A., Maggiolini M. Curr. Cancer Drug Targets 2012, 12:531-542.
32. Okada T. Biochem. Soc. Trans. 2004, 32:738-741.
33. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., Buss V.J. Mol. Biol. 2004, 342:571-583.
34. Kiefer F., Arnold K., Künzli M., Bordoli L., Schwede T. Nucleic Acids Res. 2009, 37:387-392.
35. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Nat. Chem. Biol. 2006, 2:207-212.
36. Dennis M.K., Field A.S., Burai R., Ramesh C., Petrie W.K., Bologa C.G., Oprea T.I., Yamaguchi Y., Hayashi S., Sklar L.A., Hathaway H.J., Arterburn J.B., Prossnitz E.R. J. Steroid Biochem. Mol. Biol. 2011, 127:358-366.
37. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Mol. Endocrinol. 2000, 14:1649-1660.
38. Bhowmick N.A., Neilson E.G., Moses H.L. Nature 2004, 432:332-337.
39. Tavintharan S., Lim S.C., Sum C.F. Basic Clin. Pharmacol. Toxicol. 2009, 104:206-210.
40. Popa C., Netea M.G., van Riel P.L., van der Meer J.W., Stalenhoef A.F. J. Lipid Res. 2007, 48:751-762.
41. Huang P.H., Lin C.P., Wang C.H., Chiang C.H., Tsai H.Y., Chen J.S., Lin F.Y., Leu H.B., Wu T.C., Chen J.W., Lin S.J. Angiogenesis 2012, 15:377-389.
42. Staton C.A., Reed M.W., Brown N.J. Int. J. Exp. Pathol. 2009, 90:195-221.
43. Shimo T., Nakanishi T., Nishida T., Asano M., Sasaki A., Kanyama M., Kuboki T., Matsumura T., Takigawa M. Oncology 2001, 61:315-322.
44. Peters J.U., Hert J., Bissantz C., Hillebrecht A., Gerebtzoff G., Bendels S., Tillier F., Migeon J., Fischer H., Guba W., Kansy M. Drug Discov. Today 2012, 17:325-335.
45. Yang L., Froio R.M., Sciuto T.E., Dvorak A.M., Alon R., Luscinskas F.W. Blood 2005, 106:584-592.
46. Digby J.E., McNeill E., Dyar O.J., Lam V., Greaves D.R., Choudhury R.P. Atherosclerosis 2010, 209:89-95.
47. Ungerstedt J.S., Blomback M., Soderstrom T. Clin. Exp. Immunol. 2003, 131:48-52.
48. Chakrabarti S., Davidge S.T. PLoS One 2012, 7:e52357.
49. Chen J., Cui X., Zacharek A., Jiang H., Roberts C., Zhang C., Lu M., Kapke A., Feldkamp C.S., Chopp M. Ann. Neurol. 2007, 62:49-58.
50. Kamanna V.S., Ganji S.H., Kashyap M.L. Curr. Opin. Lipidol. 2013, 24:239-245.
51. Lauring B., Taggart A.K., Tata J.R., Dunbar R., Caro L., Cheng K., Chin J., Colletti S.L., Cote J., Khalilieh S., Liu J., Luo W.L., Maclean A.A., Peterson L.B., Polis A.B., Sirah W., Wu T.J., Liu X., Jin L., Wu K., Boatman P.D., Semple G., Behan D.P., Connolly D.T., Lai E., Wagner J.A., Wright S.D., Cuffie C., Mitchel Y.B., Rader D.J., Paolini J.F., Waters M.G., Plump A. Sci. Transl. Med. 2012, 4:148ra115.
52. Ganji S.H., Tavintharan S., Zhu D., Xing Y., Kamanna V.S., Kashyap M.L. J. Lipid Res. 2004, 45:1835-1845.
53. Hernandez C., Molusky M., Li Y., Li S., Lin J.D. Cell Metab. 2010, 12:411-419.
54. Lamon-Fava S., Diffenderfer M.R., Barrett P.H., Buchsbaum A., Nyaku M., Horvath K.V., Asztalos B.F., Otokozawa S., Ai M., Matthan N.R., Lichtenstein A.H., Dolnikowski G.G., Schaefer E.J. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1672-1678.
55. Lappano R., Maggiolini M. Nat. Rev. Drug Discov. 2011, 10:47-60.